News

kliksolonews. com
bargainyotta. com > product-p-570862. html

"In October We Wear Pink" Hoodie - Breast Cancer Awareness Sweatshirt With Angel Wings, Support Survivor

38+ min ago  (273+ words) In October We Wear Pink Sweatshirt Pink Angel Wings Shirt Support Survivor Hoodie Women Breast Cancer Awareness Shirt This In October We Wear Pink Sweatshirt honors breast cancer awareness with a beautiful pink angel wings design, symbolizing hope and support…...

Symbols: symbol:these
tribtoday. com
tribtoday. com > life > lifecovers > 2026 > 05 > when-should-you-get-a-mammogram

When should you get a mammogram?

1+ day, 36+ min ago  (969+ words) AP A radiologist uses a magnifying glass to examine mammograms for breast cancer in Los Angeles, May 6, 2010. WASHINGTON " Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for…...

Symbols: wow.ax,cba.ax
BCTV
bctv. org > 05/19/2026 > breast-cancer-support-services-of-berks-county-welcomes-two-new-staff-members

Breast Cancer Support Services Welcomes Two New Staff Members

1+ hour, 4+ min ago  (327+ words) From Breast Cancer Support Services of Berks County Pictured above, from left to right: Karin Allmendinger and Katia Botelho. Breast Cancer Support Services of Berks County (BCSS) is pleased to announce that Karin Allmendinger and Katia Botelho have joined the…...

Symbols: nasdaq:smx
Pluang
pluang. com > en > news-feed > roche-sajikan-data-baru-asco-2026-potensi-giredestrant-ubah-standar-perawatan

Roche unveils promising breast cancer treatment. .. | Pluang " Crypto, Stocks, Gold & Funds

5+ hour, 50+ min ago  (243+ words) At ASCO 2026, Roche presented new data on nine cancer medicines, with a focus on giredestrant for ER-positive, HER2-negative breast cancer. Key trials showed giredestrant's potential to become a new standard of care by reducing recurrence risk and improving progression-free survival…...

Symbols: btc-usd,nyse:azn
BIOENGINEER. ORG
bioengineer. org > fgfr1-not-s6k1-2-fuels-braf-resistance

FGFR1, Not S6 K1/2, Fuels BRAF Resistance

1+ hour, 36+ min ago  (759+ words) In a groundbreaking study poised to reshape the landscape of melanoma treatment, researchers have pinpointed a key molecular pathway responsible for intrinsic resistance to BRAF inhibitors'one of the frontline therapies against this formidable skin cancer. The investigation, led by Almoiliqy,…...

Symbols: btc-usd
Trading View
tradingview. com > news > urn: summary_document_transcript: quartr. com: 3345487: 0-elut-antibiotic-eluting-matrix-targets-high-breast-reconstruction-infection-rates-in-a-1-5b-market

ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1. 5 B market

14+ hour, 7+ min ago  (75+ words) Trading View ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1. 5 B market A proven antibiotic-eluting matrix platform is being adapted for breast reconstruction, targeting a $1. 5 billion U. S. market with high infection rates. FDA approvals are expected within a…...

Symbols: nasdaq:elut,btc-usd,nasdaq:eltx
cureusinc
cureus. com > articles > 475441-predictors-of-pathological-complete-response-and-patient-reported-outcomes-during-neoadjuvant-chemotherapy-in-early-breast-cancer-a-single-center-retrospective-cohort-study

Predictors of Pathological Complete Response and Patient-Reported Outcomes During Neoadjuvant Chemotherapy in Early Breast Cancer: A Single-Center Retrospective Cohort Study

3+ hour, 2+ min ago  (227+ words) Background: Neoadjuvant chemotherapy (NAC) is the standard of care for biologically aggressive early breast cancer, and pathological complete response (p CR) is a robust surrogate of long-term outcome. Real-world cohorts integrating clinical, pathological, and patient-reported variables remain limited. Methods: We…...

Symbols: btc-usd
Medical Dialogues
medicaldialogues. in > oncology > news > fda-expands-enhertu-approval-for-early-stage-her2-positive-breast-cancer-170947

FDA Expands Enhertu Approval for Early-Stage HER2-Positive Breast Cancer

2+ hour, 48+ min ago  (355+ words) The FDA has approved two new indications for trastuzumab deruxtecan (Enhertu) in patients with early-stage HER2-positive breast cancer. One approval covers neoadjuvant treatment for stage II'III disease, using Enhertu followed by a regimen of taxane, trastuzumab (Herceptin), and pertuzumab (Perjeta)…...

Symbols: nyse:azn
Google News
newsofbahrain. com > world > 133297. html

Researchers Warn Adult Obesity Could Trigger Multiple Cancers | THE DAILY TRIBUNE | KINGDOM OF BAHRAIN

3+ hour, 10+ min ago  (198+ words) Researchers Warn Adult Obesity Could Trigger Multiple Cancers News of Bahrain Email: online@newsofbahrain. com Stockholm: According to recent research presented at the European Congress on Obesity, adults who gain significant weight later in life may have a significantly increased…...

UCLA
newsroom. ucla. edu > in-the-news > when-should-women-start-getting-mammograms

When should women start getting mammograms? " and more UCLA media

5+ hour, 39+ min ago  (334+ words) More highlights from UCLA in the News: May 18, 2026 The rapid spread demands a rapid response, says Anne Rimoin, an epidemiologist at the University of California, Los Angeles, who has worked on disease outbreaks in the [Democratic Republic of the Congo]…...

Symbols: wow.ax,cba.ax,btc-usd